

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | L-phenylalanine catabolic process (GO:0006559) | 5.34031444 |
| 2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 5.34031444 |
| 3 | lysine catabolic process (GO:0006554) | 5.25220874 |
| 4 | lysine metabolic process (GO:0006553) | 5.25220874 |
| 5 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.17788417 |
| 6 | L-phenylalanine metabolic process (GO:0006558) | 5.17788417 |
| 7 | aromatic amino acid family catabolic process (GO:0009074) | 4.73601408 |
| 8 | amino-acid betaine metabolic process (GO:0006577) | 4.58066021 |
| 9 | glyoxylate metabolic process (GO:0046487) | 4.54689910 |
| 10 | short-chain fatty acid metabolic process (GO:0046459) | 4.52333341 |
| 11 | fatty acid beta-oxidation (GO:0006635) | 4.52083672 |
| 12 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.51924194 |
| 13 | alpha-linolenic acid metabolic process (GO:0036109) | 4.51408983 |
| 14 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.47418131 |
| 15 | cellular ketone body metabolic process (GO:0046950) | 4.43676786 |
| 16 | kynurenine metabolic process (GO:0070189) | 4.37001103 |
| 17 | carnitine metabolic process (GO:0009437) | 4.31912316 |
| 18 | tryptophan catabolic process (GO:0006569) | 4.28478536 |
| 19 | indole-containing compound catabolic process (GO:0042436) | 4.28478536 |
| 20 | indolalkylamine catabolic process (GO:0046218) | 4.28478536 |
| 21 | 2-oxoglutarate metabolic process (GO:0006103) | 4.26882307 |
| 22 | carnitine shuttle (GO:0006853) | 4.21014531 |
| 23 | fatty acid transmembrane transport (GO:1902001) | 4.20645047 |
| 24 | fatty acid oxidation (GO:0019395) | 4.20302222 |
| 25 | lipid oxidation (GO:0034440) | 4.17981684 |
| 26 | cysteine metabolic process (GO:0006534) | 4.16804027 |
| 27 | * aspartate family amino acid catabolic process (GO:0009068) | 4.13434918 |
| 28 | fatty acid catabolic process (GO:0009062) | 4.10076991 |
| 29 | tryptophan metabolic process (GO:0006568) | 4.06698885 |
| 30 | bile acid biosynthetic process (GO:0006699) | 4.04654383 |
| 31 | acetyl-CoA metabolic process (GO:0006084) | 3.98774311 |
| 32 | regulation of triglyceride catabolic process (GO:0010896) | 3.91771848 |
| 33 | serine family amino acid catabolic process (GO:0009071) | 3.88487133 |
| 34 | monocarboxylic acid catabolic process (GO:0072329) | 3.86973710 |
| 35 | valine metabolic process (GO:0006573) | 3.85261379 |
| 36 | branched-chain amino acid catabolic process (GO:0009083) | 3.82509691 |
| 37 | sulfur amino acid catabolic process (GO:0000098) | 3.82027034 |
| 38 | tricarboxylic acid cycle (GO:0006099) | 3.81802056 |
| 39 | ketone body metabolic process (GO:1902224) | 3.81575641 |
| 40 | ethanol oxidation (GO:0006069) | 3.79309717 |
| 41 | fibrinolysis (GO:0042730) | 3.79249685 |
| 42 | homocysteine metabolic process (GO:0050667) | 3.77616335 |
| 43 | * alpha-amino acid catabolic process (GO:1901606) | 3.75388909 |
| 44 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.75356373 |
| 45 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.75356373 |
| 46 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.66054263 |
| 47 | branched-chain amino acid metabolic process (GO:0009081) | 3.63521739 |
| 48 | epoxygenase P450 pathway (GO:0019373) | 3.59690542 |
| 49 | * cellular amino acid catabolic process (GO:0009063) | 3.58768259 |
| 50 | biotin metabolic process (GO:0006768) | 3.58643513 |
| 51 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.57176285 |
| 52 | high-density lipoprotein particle remodeling (GO:0034375) | 3.56372914 |
| 53 | exogenous drug catabolic process (GO:0042738) | 3.55070858 |
| 54 | oligosaccharide catabolic process (GO:0009313) | 3.54101119 |
| 55 | cellular modified amino acid catabolic process (GO:0042219) | 3.52977397 |
| 56 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.50856748 |
| 57 | glutamate metabolic process (GO:0006536) | 3.50620020 |
| 58 | amino-acid betaine transport (GO:0015838) | 3.49593584 |
| 59 | carnitine transport (GO:0015879) | 3.49593584 |
| 60 | * carboxylic acid catabolic process (GO:0046395) | 3.49587690 |
| 61 | * organic acid catabolic process (GO:0016054) | 3.49587690 |
| 62 | carnitine transmembrane transport (GO:1902603) | 3.47841181 |
| 63 | regulation of sequestering of triglyceride (GO:0010889) | 3.46608933 |
| 64 | bile acid metabolic process (GO:0008206) | 3.46592251 |
| 65 | reverse cholesterol transport (GO:0043691) | 3.45394324 |
| 66 | urea metabolic process (GO:0019627) | 3.42821174 |
| 67 | urea cycle (GO:0000050) | 3.42821174 |
| 68 | succinate metabolic process (GO:0006105) | 3.42103320 |
| 69 | aromatic amino acid family metabolic process (GO:0009072) | 3.41338755 |
| 70 | positive regulation of fatty acid oxidation (GO:0046321) | 3.40996983 |
| 71 | regulation of cholesterol esterification (GO:0010872) | 3.38503831 |
| 72 | coenzyme catabolic process (GO:0009109) | 3.37800641 |
| 73 | tricarboxylic acid metabolic process (GO:0072350) | 3.36272047 |
| 74 | regulation of fatty acid oxidation (GO:0046320) | 3.36263312 |
| 75 | blood coagulation, intrinsic pathway (GO:0007597) | 3.35540660 |
| 76 | protein carboxylation (GO:0018214) | 3.34277186 |
| 77 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.34277186 |
| 78 | acylglycerol homeostasis (GO:0055090) | 3.33339924 |
| 79 | triglyceride homeostasis (GO:0070328) | 3.33339924 |
| 80 | plasma lipoprotein particle remodeling (GO:0034369) | 3.28543484 |
| 81 | protein-lipid complex remodeling (GO:0034368) | 3.28543484 |
| 82 | macromolecular complex remodeling (GO:0034367) | 3.28543484 |
| 83 | phospholipid homeostasis (GO:0055091) | 3.23374632 |
| 84 | drug catabolic process (GO:0042737) | 3.23055589 |
| 85 | regulation of protein activation cascade (GO:2000257) | 3.19681464 |
| 86 | nitrogen cycle metabolic process (GO:0071941) | 3.19440278 |
| 87 | complement activation, alternative pathway (GO:0006957) | 3.18907021 |
| 88 | negative regulation of blood coagulation (GO:0030195) | 3.17670922 |
| 89 | negative regulation of hemostasis (GO:1900047) | 3.17670922 |
| 90 | negative regulation of cholesterol transport (GO:0032375) | 3.16910589 |
| 91 | negative regulation of sterol transport (GO:0032372) | 3.16910589 |
| 92 | acute-phase response (GO:0006953) | 3.15340460 |
| 93 | tyrosine metabolic process (GO:0006570) | 3.15178041 |
| 94 | positive regulation of lipid catabolic process (GO:0050996) | 3.13467637 |
| 95 | cholesterol efflux (GO:0033344) | 3.13319250 |
| 96 | regulation of cholesterol metabolic process (GO:0090181) | 3.12481234 |
| 97 | ethanol metabolic process (GO:0006067) | 3.10893411 |
| 98 | quaternary ammonium group transport (GO:0015697) | 3.09442420 |
| 99 | negative regulation of fibrinolysis (GO:0051918) | 3.09386352 |
| 100 | fatty acid homeostasis (GO:0055089) | 3.09064115 |
| 101 | indolalkylamine metabolic process (GO:0006586) | 3.07871252 |
| 102 | low-density lipoprotein particle remodeling (GO:0034374) | 3.07549792 |
| 103 | drug transmembrane transport (GO:0006855) | 3.06301676 |
| 104 | omega-hydroxylase P450 pathway (GO:0097267) | 3.05465097 |
| 105 | plasma lipoprotein particle clearance (GO:0034381) | 3.05254285 |
| 106 | regulation of fibrinolysis (GO:0051917) | 3.04500523 |
| 107 | positive regulation of lipid storage (GO:0010884) | 3.04154837 |
| 108 | regulation of cholesterol storage (GO:0010885) | 3.03326058 |
| 109 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 3.03036902 |
| 110 | phospholipid efflux (GO:0033700) | 3.02497846 |
| 111 | NADH metabolic process (GO:0006734) | 3.02413344 |
| 112 | drug metabolic process (GO:0017144) | 3.02161119 |
| 113 | xenobiotic catabolic process (GO:0042178) | 3.01196702 |
| 114 | regulation of complement activation (GO:0030449) | 2.99681043 |
| 115 | cellular glucuronidation (GO:0052695) | 2.98288378 |
| 116 | negative regulation of protein activation cascade (GO:2000258) | 2.96313626 |
| 117 | glucuronate metabolic process (GO:0019585) | 2.95804863 |
| 118 | uronic acid metabolic process (GO:0006063) | 2.95804863 |
| 119 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.95081413 |
| 120 | fat-soluble vitamin biosynthetic process (GO:0042362) | 2.94693203 |
| 121 | * small molecule catabolic process (GO:0044282) | 2.94425917 |
| 122 | cellular biogenic amine catabolic process (GO:0042402) | 2.94143670 |
| 123 | amine catabolic process (GO:0009310) | 2.94143670 |
| 124 | benzene-containing compound metabolic process (GO:0042537) | 2.92592181 |
| 125 | glucosamine-containing compound catabolic process (GO:1901072) | 2.92358470 |
| 126 | negative regulation of coagulation (GO:0050819) | 2.92046523 |
| 127 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.91017144 |
| 128 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.84854807 |
| 129 | negative regulation of complement activation (GO:0045916) | 2.74749933 |
| 130 | muscle filament sliding (GO:0030049) | 2.73538000 |
| 131 | actin-myosin filament sliding (GO:0033275) | 2.73538000 |
| 132 | negative regulation of wound healing (GO:0061045) | 2.70264187 |
| 133 | creatine metabolic process (GO:0006600) | 2.70211722 |
| 134 | oxaloacetate metabolic process (GO:0006107) | 2.68818879 |
| 135 | regulation of apoptotic cell clearance (GO:2000425) | 2.68793303 |
| 136 | regulation of humoral immune response (GO:0002920) | 2.65888658 |
| 137 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 2.65308547 |
| 138 | protein activation cascade (GO:0072376) | 2.63157984 |
| 139 | positive regulation of blood coagulation (GO:0030194) | 2.62994770 |
| 140 | positive regulation of hemostasis (GO:1900048) | 2.62994770 |
| 141 | response to muscle activity (GO:0014850) | 2.62450902 |
| 142 | regulation of fatty acid biosynthetic process (GO:0042304) | 2.58539785 |
| 143 | regulation of skeletal muscle contraction (GO:0014819) | 2.57069840 |
| 144 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 2.54931292 |
| 145 | positive regulation of chemokine secretion (GO:0090197) | 2.52742773 |
| 146 | plasma lipoprotein particle organization (GO:0071827) | 2.52620828 |
| 147 | low-density lipoprotein particle clearance (GO:0034383) | 2.51809164 |
| 148 | amino sugar catabolic process (GO:0046348) | 2.51682049 |
| 149 | plasma lipoprotein particle assembly (GO:0034377) | 2.50937021 |
| 150 | positive regulation of coagulation (GO:0050820) | 2.48625036 |
| 151 | protein-lipid complex subunit organization (GO:0071825) | 2.48322429 |
| 152 | negative regulation of lipase activity (GO:0060192) | 2.47791628 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 7.66850305 |
| 2 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.58359839 |
| 3 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 5.52081022 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.99894671 |
| 5 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.91345192 |
| 6 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.74591064 |
| 7 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.57134487 |
| 8 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 3.84268151 |
| 9 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.77315795 |
| 10 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.41745789 |
| 11 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.20052572 |
| 12 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.66583469 |
| 13 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.51189466 |
| 14 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.47970505 |
| 15 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.06083987 |
| 16 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.05062939 |
| 17 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.99495132 |
| 18 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.96967546 |
| 19 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.96786983 |
| 20 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.86735367 |
| 21 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.80633876 |
| 22 | GATA1_22025678_ChIP-Seq_K562_Human | 1.71618557 |
| 23 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.66412779 |
| 24 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.64626670 |
| 25 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.61785504 |
| 26 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.60708387 |
| 27 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.60339747 |
| 28 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.59146024 |
| 29 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.55760651 |
| 30 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.52789279 |
| 31 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.52697035 |
| 32 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.51352736 |
| 33 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.50394520 |
| 34 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.37219747 |
| 35 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.36615441 |
| 36 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.36128479 |
| 37 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.34395422 |
| 38 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.34395422 |
| 39 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.33314884 |
| 40 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.30987519 |
| 41 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.30400014 |
| 42 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.29728623 |
| 43 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.29490255 |
| 44 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.24219903 |
| 45 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.23848490 |
| 46 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.21170408 |
| 47 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.21041871 |
| 48 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.14782517 |
| 49 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.13219615 |
| 50 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.12827508 |
| 51 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.12827508 |
| 52 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.12696590 |
| 53 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.11951876 |
| 54 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.08860845 |
| 55 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.08719865 |
| 56 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.07951813 |
| 57 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.07037369 |
| 58 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.06776978 |
| 59 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.06711866 |
| 60 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.06030846 |
| 61 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.03982181 |
| 62 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.03202621 |
| 63 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.03185468 |
| 64 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.03104290 |
| 65 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.02734506 |
| 66 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.02128231 |
| 67 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.99836755 |
| 68 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.99773069 |
| 69 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.98924957 |
| 70 | GBX2_23144817_ChIP-Seq_PC3_Human | 0.98283540 |
| 71 | * AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.94891457 |
| 72 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.93963744 |
| 73 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.93778320 |
| 74 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.93437309 |
| 75 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.93058299 |
| 76 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.92880293 |
| 77 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.92305983 |
| 78 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.91215164 |
| 79 | SPI1_23127762_ChIP-Seq_K562_Human | 0.91112781 |
| 80 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.90051233 |
| 81 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.89969753 |
| 82 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.89477395 |
| 83 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 0.88825272 |
| 84 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.86176928 |
| 85 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.84593510 |
| 86 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.84422823 |
| 87 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.83408229 |
| 88 | EZH2_22144423_ChIP-Seq_EOC_Human | 0.82445182 |
| 89 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.82136565 |
| 90 | RXR_22108803_ChIP-Seq_LS180_Human | 0.81924281 |
| 91 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.81670922 |
| 92 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.81108066 |
| 93 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.79765450 |
| 94 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.79483251 |
| 95 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.79441976 |
| 96 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.78838804 |
| 97 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.78423115 |
| 98 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 0.78233783 |
| 99 | CJUN_26792858_Chip-Seq_BT549_Human | 0.78040741 |
| 100 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.77660464 |
| 101 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.77493244 |
| 102 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.77189196 |
| 103 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.76882400 |
| 104 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.76601981 |
| 105 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.74428255 |
| 106 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.73001569 |
| 107 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.72474421 |
| 108 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 0.72118120 |
| 109 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 0.71918429 |
| 110 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.71715690 |
| 111 | AR_20517297_ChIP-Seq_VCAP_Human | 0.70761555 |
| 112 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.70312090 |
| 113 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.69902767 |
| 114 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.69270872 |
| 115 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 0.69213640 |
| 116 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 0.69213640 |
| 117 | CBP_21632823_ChIP-Seq_H3396_Human | 0.68976532 |
| 118 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.68745547 |
| 119 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.68533744 |
| 120 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.67977747 |
| 121 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.67861698 |
| 122 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.67857802 |
| 123 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.67410110 |
| 124 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.66880697 |
| 125 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.66801458 |
| 126 | * RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.66607074 |
| 127 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.66350488 |
| 128 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.66182391 |
| 129 | GATA2_19941826_ChIP-Seq_K562_Human | 0.65837742 |
| 130 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.65391244 |
| 131 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.64689024 |
| 132 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.64534702 |
| 133 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.63879499 |
| 134 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.63492558 |
| 135 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.63457520 |
| 136 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.63457520 |
| 137 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.63333192 |
| 138 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.62995552 |
| 139 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.62986781 |
| 140 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.62790271 |
| 141 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.62189816 |
| 142 | * SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.61514649 |
| 143 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.61136862 |
| 144 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.60555269 |
| 145 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.60473233 |
| 146 | AR_25329375_ChIP-Seq_VCAP_Human | 0.60186514 |
| 147 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.59943712 |
| 148 | * EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.59870300 |
| 149 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 0.59195019 |
| 150 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.59188951 |
| 151 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.58937348 |
| 152 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.58871430 |
| 153 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.58503156 |
| 154 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.58463211 |
| 155 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.57851910 |
| 156 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.57278165 |
| 157 | GATA1_19941826_ChIP-Seq_K562_Human | 0.57227643 |
| 158 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.56554419 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 5.91603207 |
| 2 | MP0005360_urolithiasis | 5.36902931 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 4.70447600 |
| 4 | MP0005365_abnormal_bile_salt | 4.62239264 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 3.61713766 |
| 6 | MP0002837_dystrophic_cardiac_calcinosis | 3.55192085 |
| 7 | MP0003646_muscle_fatigue | 3.09042804 |
| 8 | MP0003806_abnormal_nucleotide_metabolis | 3.03610538 |
| 9 | MP0003252_abnormal_bile_duct | 2.82718253 |
| 10 | MP0010329_abnormal_lipoprotein_level | 2.81507579 |
| 11 | * MP0005332_abnormal_amino_acid | 2.72524734 |
| 12 | MP0003195_calcinosis | 2.57565806 |
| 13 | MP0004130_abnormal_muscle_cell | 2.43423115 |
| 14 | MP0005083_abnormal_biliary_tract | 2.34994333 |
| 15 | MP0005670_abnormal_white_adipose | 2.32064343 |
| 16 | MP0009840_abnormal_foam_cell | 2.29091086 |
| 17 | MP0000751_myopathy | 2.18541951 |
| 18 | MP0004215_abnormal_myocardial_fiber | 2.17670701 |
| 19 | MP0001666_abnormal_nutrient_absorption | 2.05523256 |
| 20 | MP0002118_abnormal_lipid_homeostasis | 2.01571550 |
| 21 | MP0003303_peritoneal_inflammation | 1.93017738 |
| 22 | MP0004084_abnormal_cardiac_muscle | 1.87181659 |
| 23 | MP0005330_cardiomyopathy | 1.84246309 |
| 24 | MP0004036_abnormal_muscle_relaxation | 1.83984335 |
| 25 | MP0006036_abnormal_mitochondrial_physio | 1.83885404 |
| 26 | MP0004043_abnormal_pH_regulation | 1.83701108 |
| 27 | MP0005058_abnormal_lysosome_morphology | 1.78737254 |
| 28 | MP0003724_increased_susceptibility_to | 1.75862975 |
| 29 | MP0000749_muscle_degeneration | 1.75576028 |
| 30 | MP0004019_abnormal_vitamin_homeostasis | 1.73948275 |
| 31 | MP0005319_abnormal_enzyme/_coenzyme | 1.62975893 |
| 32 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.61800025 |
| 33 | MP0000609_abnormal_liver_physiology | 1.57442720 |
| 34 | MP0001835_abnormal_antigen_presentation | 1.56594480 |
| 35 | MP0005666_abnormal_adipose_tissue | 1.54057345 |
| 36 | MP0003191_abnormal_cellular_cholesterol | 1.53515118 |
| 37 | MP0009785_altered_susceptibility_to | 1.50815039 |
| 38 | MP0002138_abnormal_hepatobiliary_system | 1.46223313 |
| 39 | MP0005464_abnormal_platelet_physiology | 1.45368456 |
| 40 | MP0009643_abnormal_urine_homeostasis | 1.45026774 |
| 41 | MP0002148_abnormal_hypersensitivity_rea | 1.44162481 |
| 42 | MP0002972_abnormal_cardiac_muscle | 1.39674998 |
| 43 | MP0002971_abnormal_brown_adipose | 1.38690329 |
| 44 | MP0003137_abnormal_impulse_conducting | 1.36804146 |
| 45 | MP0005620_abnormal_muscle_contractility | 1.35990013 |
| 46 | MP0003436_decreased_susceptibility_to | 1.34275811 |
| 47 | MP0004087_abnormal_muscle_fiber | 1.32040732 |
| 48 | MP0008469_abnormal_protein_level | 1.30829453 |
| 49 | MP0003879_abnormal_hair_cell | 1.27676491 |
| 50 | MP0003300_gastrointestinal_ulcer | 1.26477523 |
| 51 | MP0003690_abnormal_glial_cell | 1.26019461 |
| 52 | MP0000343_altered_response_to | 1.25852814 |
| 53 | MP0003868_abnormal_feces_composition | 1.25626130 |
| 54 | MP0005535_abnormal_body_temperature | 1.23911269 |
| 55 | MP0008775_abnormal_heart_ventricle | 1.23047968 |
| 56 | MP0002078_abnormal_glucose_homeostasis | 1.20853501 |
| 57 | MP0002269_muscular_atrophy | 1.19449057 |
| 58 | MP0004510_myositis | 1.19210368 |
| 59 | MP0006082_CNS_inflammation | 1.18239864 |
| 60 | MP0002419_abnormal_innate_immunity | 1.17776258 |
| 61 | MP0003950_abnormal_plasma_membrane | 1.14140959 |
| 62 | MP0003186_abnormal_redox_activity | 1.12787632 |
| 63 | MP0005385_cardiovascular_system_phenoty | 1.11804792 |
| 64 | MP0001544_abnormal_cardiovascular_syste | 1.11804792 |
| 65 | MP0004145_abnormal_muscle_electrophysio | 1.08390805 |
| 66 | MP0001764_abnormal_homeostasis | 1.05513915 |
| 67 | MP0006138_congestive_heart_failure | 1.05226500 |
| 68 | MP0003172_abnormal_lysosome_physiology | 1.03461358 |
| 69 | MP0000747_muscle_weakness | 1.02492358 |
| 70 | MP0006035_abnormal_mitochondrial_morpho | 1.02181834 |
| 71 | MP0009697_abnormal_copulation | 1.02067871 |
| 72 | MP0005166_decreased_susceptibility_to | 1.00469794 |
| 73 | MP0005636_abnormal_mineral_homeostasis | 1.00452408 |
| 74 | MP0005025_abnormal_response_to | 0.99791156 |
| 75 | MP0002106_abnormal_muscle_physiology | 0.99631525 |
| 76 | MP0000750_abnormal_muscle_regeneration | 0.99493209 |
| 77 | MP0001790_abnormal_immune_system | 0.98849364 |
| 78 | MP0005387_immune_system_phenotype | 0.98849364 |
| 79 | MP0009780_abnormal_chondrocyte_physiolo | 0.98543129 |
| 80 | MP0002876_abnormal_thyroid_physiology | 0.97815506 |
| 81 | MP0004484_altered_response_of | 0.95691312 |
| 82 | MP0004085_abnormal_heartbeat | 0.93708023 |
| 83 | MP0002332_abnormal_exercise_endurance | 0.93057429 |
| 84 | MP0005334_abnormal_fat_pad | 0.92617714 |
| 85 | MP0010630_abnormal_cardiac_muscle | 0.91245339 |
| 86 | MP0000685_abnormal_immune_system | 0.89555299 |
| 87 | MP0000230_abnormal_systemic_arterial | 0.88060378 |
| 88 | MP0001845_abnormal_inflammatory_respons | 0.88031366 |
| 89 | MP0003329_amyloid_beta_deposits | 0.87019900 |
| 90 | MP0004233_abnormal_muscle_weight | 0.86092176 |
| 91 | MP0003828_pulmonary_edema | 0.85856213 |
| 92 | MP0001533_abnormal_skeleton_physiology | 0.85780742 |
| 93 | MP0005266_abnormal_metabolism | 0.84897725 |
| 94 | MP0005375_adipose_tissue_phenotype | 0.84479332 |
| 95 | MP0005000_abnormal_immune_tolerance | 0.84372785 |
| 96 | MP0005451_abnormal_body_composition | 0.83992976 |
| 97 | MP0003183_abnormal_peptide_metabolism | 0.83877400 |
| 98 | MP0002132_abnormal_respiratory_system | 0.83363385 |
| 99 | MP0001756_abnormal_urination | 0.83016375 |
| 100 | MP0005165_increased_susceptibility_to | 0.82446525 |
| 101 | MP0005369_muscle_phenotype | 0.80534505 |
| 102 | MP0005164_abnormal_response_to | 0.78274775 |
| 103 | MP0000249_abnormal_blood_vessel | 0.77758475 |
| 104 | MP0001765_abnormal_ion_homeostasis | 0.76411163 |
| 105 | MP0005647_abnormal_sex_gland | 0.75338241 |
| 106 | MP0005448_abnormal_energy_balance | 0.74705704 |
| 107 | MP0000604_amyloidosis | 0.74048980 |
| 108 | MP0009642_abnormal_blood_homeostasis | 0.73851105 |
| 109 | MP0002909_abnormal_adrenal_gland | 0.73799583 |
| 110 | MP0009764_decreased_sensitivity_to | 0.73296527 |
| 111 | MP0004185_abnormal_adipocyte_glucose | 0.71889734 |
| 112 | MP0000759_abnormal_skeletal_muscle | 0.71603796 |
| 113 | MP0009384_cardiac_valve_regurgitation | 0.70847997 |
| 114 | MP0010368_abnormal_lymphatic_system | 0.70589821 |
| 115 | MP0002254_reproductive_system_inflammat | 0.69186909 |
| 116 | MP0009115_abnormal_fat_cell | 0.66983905 |
| 117 | MP0005167_abnormal_blood-brain_barrier | 0.66499649 |
| 118 | MP0003656_abnormal_erythrocyte_physiolo | 0.65922124 |
| 119 | MP0003953_abnormal_hormone_level | 0.65556101 |
| 120 | MP0003011_delayed_dark_adaptation | 0.64301588 |
| 121 | MP0005376_homeostasis/metabolism_phenot | 0.63906100 |
| 122 | MP0005084_abnormal_gallbladder_morpholo | 0.62277626 |
| 123 | MP0001853_heart_inflammation | 0.61465001 |
| 124 | MP0000598_abnormal_liver_morphology | 0.60971236 |
| 125 | MP0001661_extended_life_span | 0.58959243 |
| 126 | MP0005220_abnormal_exocrine_pancreas | 0.56073658 |
| 127 | MP0003221_abnormal_cardiomyocyte_apopto | 0.55591334 |
| 128 | MP0001984_abnormal_olfaction | 0.54392950 |
| 129 | MP0002127_abnormal_cardiovascular_syste | 0.53464325 |
| 130 | MP0003075_altered_response_to | 0.52827176 |
| 131 | MP0009763_increased_sensitivity_to | 0.52712046 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hypoglycemic coma (HP:0001325) | 4.97187713 |
| 2 | Systemic lupus erythematosus (HP:0002725) | 4.75340221 |
| 3 | Hyperglycinuria (HP:0003108) | 4.74744188 |
| 4 | Ketosis (HP:0001946) | 4.67981265 |
| 5 | Ketoacidosis (HP:0001993) | 4.57611488 |
| 6 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.54303812 |
| 7 | Intrahepatic cholestasis (HP:0001406) | 4.45928023 |
| 8 | Hyperammonemia (HP:0001987) | 4.34265584 |
| 9 | Abnormality of glycine metabolism (HP:0010895) | 4.31022548 |
| 10 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.31022548 |
| 11 | Xanthomatosis (HP:0000991) | 4.24419355 |
| 12 | Hyperglycinemia (HP:0002154) | 4.19413858 |
| 13 | Abnormality of fatty-acid metabolism (HP:0004359) | 4.16290353 |
| 14 | Hyperlipoproteinemia (HP:0010980) | 4.11921538 |
| 15 | Deep venous thrombosis (HP:0002625) | 4.00390590 |
| 16 | Myoglobinuria (HP:0002913) | 3.96040533 |
| 17 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.94435438 |
| 18 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.94435438 |
| 19 | Abnormality of glycolipid metabolism (HP:0010969) | 3.94435438 |
| 20 | Abnormality of complement system (HP:0005339) | 3.81536487 |
| 21 | Hypoalphalipoproteinemia (HP:0003233) | 3.68813138 |
| 22 | Exercise-induced myalgia (HP:0003738) | 3.64021949 |
| 23 | Nemaline bodies (HP:0003798) | 3.63319199 |
| 24 | Prolonged partial thromboplastin time (HP:0003645) | 3.62764622 |
| 25 | Muscle fiber inclusion bodies (HP:0100299) | 3.59780574 |
| 26 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 3.59511231 |
| 27 | Dicarboxylic aciduria (HP:0003215) | 3.59511231 |
| 28 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.52232199 |
| 29 | Glomerulonephritis (HP:0000099) | 3.46772404 |
| 30 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 3.45357449 |
| 31 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.31665413 |
| 32 | Hypolipoproteinemia (HP:0010981) | 3.29550960 |
| 33 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.24914869 |
| 34 | Sudden death (HP:0001699) | 3.24675474 |
| 35 | Gout (HP:0001997) | 3.22662856 |
| 36 | Hypobetalipoproteinemia (HP:0003563) | 3.21491295 |
| 37 | Generalized aminoaciduria (HP:0002909) | 3.06945702 |
| 38 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.06150508 |
| 39 | Metabolic acidosis (HP:0001942) | 3.05285544 |
| 40 | Hyperinsulinemic hypoglycemia (HP:0000825) | 3.04959822 |
| 41 | Hypoglycemic seizures (HP:0002173) | 3.03044998 |
| 42 | Exercise-induced muscle cramps (HP:0003710) | 2.97333640 |
| 43 | Cerebral edema (HP:0002181) | 2.95367478 |
| 44 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.87576482 |
| 45 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.87123153 |
| 46 | Abnormality of serum amino acid levels (HP:0003112) | 2.85666875 |
| 47 | Abnormality of purine metabolism (HP:0004352) | 2.82269451 |
| 48 | Complement deficiency (HP:0004431) | 2.79694631 |
| 49 | Rhabdomyolysis (HP:0003201) | 2.76987068 |
| 50 | Lethargy (HP:0001254) | 2.76365854 |
| 51 | Calf muscle hypertrophy (HP:0008981) | 2.74730196 |
| 52 | Delayed CNS myelination (HP:0002188) | 2.69276133 |
| 53 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.69173778 |
| 54 | Epidermoid cyst (HP:0200040) | 2.68203253 |
| 55 | Joint hemorrhage (HP:0005261) | 2.64596153 |
| 56 | Purpura (HP:0000979) | 2.63968974 |
| 57 | Type 1 muscle fiber predominance (HP:0003803) | 2.62974876 |
| 58 | Ventricular tachycardia (HP:0004756) | 2.61616666 |
| 59 | Right ventricular cardiomyopathy (HP:0011663) | 2.60072781 |
| 60 | Proximal tubulopathy (HP:0000114) | 2.58558454 |
| 61 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.58172611 |
| 62 | Renal cortical cysts (HP:0000803) | 2.56917950 |
| 63 | Palpitations (HP:0001962) | 2.54226598 |
| 64 | Increased purine levels (HP:0004368) | 2.52665281 |
| 65 | Hyperuricemia (HP:0002149) | 2.52665281 |
| 66 | Abnormality of methionine metabolism (HP:0010901) | 2.51235115 |
| 67 | Conjugated hyperbilirubinemia (HP:0002908) | 2.51092384 |
| 68 | Hepatic necrosis (HP:0002605) | 2.43043388 |
| 69 | EMG: myopathic abnormalities (HP:0003458) | 2.41752565 |
| 70 | Vomiting (HP:0002013) | 2.41578164 |
| 71 | Myocardial infarction (HP:0001658) | 2.41235647 |
| 72 | Acute encephalopathy (HP:0006846) | 2.39780345 |
| 73 | Atrioventricular block (HP:0001678) | 2.38849156 |
| 74 | Hyperbilirubinemia (HP:0002904) | 2.37443786 |
| 75 | Fat malabsorption (HP:0002630) | 2.37382068 |
| 76 | Late onset (HP:0003584) | 2.36768315 |
| 77 | Abnormality of nucleobase metabolism (HP:0010932) | 2.36006850 |
| 78 | Syncope (HP:0001279) | 2.35970340 |
| 79 | Abnormality of the common coagulation pathway (HP:0010990) | 2.34040028 |
| 80 | Vascular calcification (HP:0004934) | 2.33641304 |
| 81 | Atrial fibrillation (HP:0005110) | 2.31538033 |
| 82 | Steatorrhea (HP:0002570) | 2.29114387 |
| 83 | Distal lower limb muscle weakness (HP:0009053) | 2.28158442 |
| 84 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.27813585 |
| 85 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.27813585 |
| 86 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.27813585 |
| 87 | Muscle fiber splitting (HP:0003555) | 2.26927032 |
| 88 | Pulmonary embolism (HP:0002204) | 2.24376198 |
| 89 | Abnormality of proline metabolism (HP:0010907) | 2.23816598 |
| 90 | Hydroxyprolinuria (HP:0003080) | 2.23816598 |
| 91 | Nephritis (HP:0000123) | 2.23698669 |
| 92 | Increased muscle lipid content (HP:0009058) | 2.22877228 |
| 93 | Heart block (HP:0012722) | 2.21655972 |
| 94 | Dysostosis multiplex (HP:0000943) | 2.20098635 |
| 95 | Methylmalonic aciduria (HP:0012120) | 2.20015017 |
| 96 | Hyporeflexia of lower limbs (HP:0002600) | 2.17769104 |
| 97 | Asymmetric septal hypertrophy (HP:0001670) | 2.17704690 |
| 98 | Abnormality of the calf musculature (HP:0001430) | 2.16314944 |
| 99 | Abnormality of urine glucose concentration (HP:0011016) | 2.16131680 |
| 100 | Glycosuria (HP:0003076) | 2.16131680 |
| 101 | Lipoatrophy (HP:0100578) | 2.15996833 |
| 102 | Abnormality of the intrinsic pathway (HP:0010989) | 2.15541782 |
| 103 | Mucopolysacchariduria (HP:0008155) | 2.15292033 |
| 104 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.15292033 |
| 105 | Dilated cardiomyopathy (HP:0001644) | 2.15221198 |
| 106 | Symptomatic seizures (HP:0011145) | 2.12859723 |
| 107 | Hypercholesterolemia (HP:0003124) | 2.12801220 |
| 108 | Gingival bleeding (HP:0000225) | 2.11747799 |
| 109 | Skin nodule (HP:0200036) | 2.10940453 |
| 110 | Increased serum ferritin (HP:0003281) | 2.10837221 |
| 111 | Amyloidosis (HP:0011034) | 2.09773969 |
| 112 | Hyperglycemia (HP:0003074) | 2.09277863 |
| 113 | Primary atrial arrhythmia (HP:0001692) | 2.08227703 |
| 114 | Vacuolated lymphocytes (HP:0001922) | 2.07994225 |
| 115 | Enlarged kidneys (HP:0000105) | 2.07422932 |
| 116 | Cardiovascular calcification (HP:0011915) | 2.06632139 |
| 117 | Rimmed vacuoles (HP:0003805) | 2.05840826 |
| 118 | Cholelithiasis (HP:0001081) | 2.05109098 |
| 119 | Abnormal gallbladder morphology (HP:0012437) | 2.04012882 |
| 120 | Thrombophlebitis (HP:0004418) | 2.02471845 |
| 121 | Abnormal atrioventricular conduction (HP:0005150) | 2.02300787 |
| 122 | Bundle branch block (HP:0011710) | 2.01081232 |
| 123 | Arterial thrombosis (HP:0004420) | 1.99353531 |
| 124 | Sensorimotor neuropathy (HP:0007141) | 1.97490479 |
| 125 | Methylmalonic acidemia (HP:0002912) | 1.97442322 |
| 126 | Alkalosis (HP:0001948) | 1.95580495 |
| 127 | Nausea (HP:0002018) | 1.95442866 |
| 128 | Ventricular arrhythmia (HP:0004308) | 1.95194625 |
| 129 | Increased serum pyruvate (HP:0003542) | 1.95085264 |
| 130 | Distal arthrogryposis (HP:0005684) | 1.94628681 |
| 131 | Neck muscle weakness (HP:0000467) | 1.94152539 |
| 132 | Increased cerebral lipofuscin (HP:0011813) | 1.93602486 |
| 133 | Supraventricular tachycardia (HP:0004755) | 1.93483950 |
| 134 | Lactic acidosis (HP:0003128) | 1.93214643 |
| 135 | Abnormal mitochondria in muscle tissue (HP:0008316) | 1.92985099 |
| 136 | Orchitis (HP:0100796) | 1.90237479 |
| 137 | Spontaneous abortion (HP:0005268) | 1.90171877 |
| 138 | Retrobulbar optic neuritis (HP:0100654) | 1.89812735 |
| 139 | Optic neuritis (HP:0100653) | 1.89812735 |
| 140 | Hemorrhage of the eye (HP:0011885) | 1.89229650 |
| 141 | Abnormality of iron homeostasis (HP:0011031) | 1.87738054 |
| 142 | Nuclear cataract (HP:0100018) | 1.83828565 |
| 143 | Myositis (HP:0100614) | 1.82435559 |
| 144 | Gangrene (HP:0100758) | 1.81199714 |
| 145 | Loss of speech (HP:0002371) | 1.77310856 |
| 146 | Abnormality of the periventricular white matter (HP:0002518) | 1.75257775 |
| 147 | Esophageal neoplasm (HP:0100751) | 1.74330720 |
| 148 | Neoplasm of head and neck (HP:0012288) | 1.74330720 |
| 149 | Reduced antithrombin III activity (HP:0001976) | 1.73040332 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 5.07809401 |
| 2 | SIK1 | 3.65302530 |
| 3 | INSRR | 3.31660068 |
| 4 | PHKG2 | 3.19480521 |
| 5 | PHKG1 | 3.19480521 |
| 6 | LMTK2 | 3.11976003 |
| 7 | TBK1 | 2.96838498 |
| 8 | TTN | 2.76563232 |
| 9 | PDK3 | 2.74410891 |
| 10 | PDK4 | 2.74410891 |
| 11 | OBSCN | 2.61602386 |
| 12 | PINK1 | 2.43806197 |
| 13 | TRIB3 | 2.19226302 |
| 14 | EIF2AK3 | 2.00572431 |
| 15 | MAP3K14 | 1.99739286 |
| 16 | WNK4 | 1.92607561 |
| 17 | KIT | 1.91265529 |
| 18 | IKBKE | 1.89168744 |
| 19 | TRPM7 | 1.75511578 |
| 20 | PDK2 | 1.67738708 |
| 21 | TIE1 | 1.65289448 |
| 22 | FGFR4 | 1.61204910 |
| 23 | MAPK15 | 1.59070054 |
| 24 | PKN2 | 1.57488496 |
| 25 | ERN1 | 1.55922919 |
| 26 | NME2 | 1.54402448 |
| 27 | LATS1 | 1.53114522 |
| 28 | MYLK | 1.49525421 |
| 29 | MAP2K4 | 1.45285238 |
| 30 | PRKAA2 | 1.43019033 |
| 31 | STK38L | 1.33474703 |
| 32 | MAP3K7 | 1.31541886 |
| 33 | PIK3CG | 1.31017433 |
| 34 | ZAP70 | 1.29938613 |
| 35 | BMPR1B | 1.29288840 |
| 36 | MAPK12 | 1.27840734 |
| 37 | PIK3CA | 1.27124965 |
| 38 | SYK | 1.25881874 |
| 39 | IRAK4 | 1.25387526 |
| 40 | PAK3 | 1.22383520 |
| 41 | BMPR2 | 1.22293711 |
| 42 | SGK2 | 1.20252323 |
| 43 | MUSK | 1.19451600 |
| 44 | SGK3 | 1.19071773 |
| 45 | BLK | 1.16004603 |
| 46 | CSF1R | 1.13700624 |
| 47 | IKBKB | 1.11139425 |
| 48 | MAPKAPK3 | 1.09000640 |
| 49 | PRKAA1 | 1.08925147 |
| 50 | DMPK | 1.06628367 |
| 51 | SGK223 | 1.06617513 |
| 52 | SGK494 | 1.06617513 |
| 53 | MATK | 0.99590957 |
| 54 | CAMK1D | 0.98949418 |
| 55 | FLT3 | 0.98079772 |
| 56 | FGFR3 | 0.95730910 |
| 57 | ERBB3 | 0.94544716 |
| 58 | EIF2AK2 | 0.91070806 |
| 59 | CAMK2G | 0.87716220 |
| 60 | TAOK3 | 0.85613852 |
| 61 | EPHA4 | 0.83434560 |
| 62 | ACVR1B | 0.83162124 |
| 63 | CAMK2D | 0.82777512 |
| 64 | ERBB4 | 0.82665232 |
| 65 | MOS | 0.81798359 |
| 66 | MAP3K11 | 0.81494196 |
| 67 | DAPK2 | 0.77507675 |
| 68 | PTK6 | 0.76057050 |
| 69 | STK38 | 0.76052114 |
| 70 | MST1R | 0.75451870 |
| 71 | FRK | 0.74923880 |
| 72 | PRKD1 | 0.73973842 |
| 73 | CAMK1G | 0.73586525 |
| 74 | RIPK4 | 0.73418554 |
| 75 | MAPK11 | 0.72771387 |
| 76 | NEK1 | 0.72692998 |
| 77 | PRKG1 | 0.72673167 |
| 78 | WNK3 | 0.72242993 |
| 79 | PRKACG | 0.71030285 |
| 80 | CAMKK2 | 0.70921054 |
| 81 | OXSR1 | 0.70825345 |
| 82 | IRAK3 | 0.70067358 |
| 83 | EPHB1 | 0.69648351 |
| 84 | PDPK1 | 0.68963045 |
| 85 | SCYL2 | 0.67646626 |
| 86 | ADRBK2 | 0.67406836 |
| 87 | TEC | 0.66050210 |
| 88 | TGFBR1 | 0.65455649 |
| 89 | PIM2 | 0.65196600 |
| 90 | LIMK1 | 0.64906509 |
| 91 | TAOK2 | 0.63151889 |
| 92 | CAMK4 | 0.61748904 |
| 93 | GRK7 | 0.59749024 |
| 94 | MAPK7 | 0.59561392 |
| 95 | NEK9 | 0.59248975 |
| 96 | MAP2K3 | 0.58618350 |
| 97 | PRKG2 | 0.58246379 |
| 98 | EPHA3 | 0.58084380 |
| 99 | ABL1 | 0.58029029 |
| 100 | HIPK2 | 0.58013515 |
| 101 | JAK1 | 0.57730102 |
| 102 | RIPK1 | 0.57638836 |
| 103 | IGF1R | 0.57636850 |
| 104 | STK39 | 0.56403714 |
| 105 | MAP2K6 | 0.56141957 |
| 106 | MAP3K6 | 0.55935143 |
| 107 | LCK | 0.54211866 |
| 108 | JAK2 | 0.53689923 |
| 109 | LYN | 0.53559075 |
| 110 | IRAK2 | 0.53535558 |
| 111 | STK24 | 0.53306446 |
| 112 | CAMK2A | 0.52618225 |
| 113 | MAP2K2 | 0.52540841 |
| 114 | PRKCE | 0.51665347 |
| 115 | PRKCH | 0.51347636 |
| 116 | PRKD3 | 0.50577108 |
| 117 | PRKACA | 0.49998552 |
| 118 | WNK1 | 0.49757423 |
| 119 | MET | 0.49460415 |
| 120 | MAP3K3 | 0.46652171 |
| 121 | PKN1 | 0.46576612 |
| 122 | ROCK1 | 0.46315576 |
| 123 | TGFBR2 | 0.46193100 |
| 124 | IRAK1 | 0.45261257 |
| 125 | CDC42BPA | 0.43652669 |
| 126 | MAP3K5 | 0.43634704 |
| 127 | FGFR2 | 0.43487044 |
| 128 | ABL2 | 0.43212846 |
| 129 | FES | 0.41436027 |
| 130 | NTRK2 | 0.41074713 |
| 131 | MAP3K4 | 0.41036164 |
| 132 | PRKCG | 0.40636184 |
| 133 | MARK3 | 0.40280079 |
| 134 | PDK1 | 0.39986632 |
| 135 | GSK3A | 0.39426770 |
| 136 | PRKCZ | 0.38904043 |
| 137 | PRKCQ | 0.38608494 |
| 138 | MAPK4 | 0.38468972 |
| 139 | FER | 0.37393216 |
| 140 | LATS2 | 0.36894813 |
| 141 | PDGFRA | 0.36689588 |
| 142 | HCK | 0.36011172 |
| 143 | TYK2 | 0.35710832 |
| 144 | SGK1 | 0.34996577 |
| 145 | PRPF4B | 0.34697304 |
| 146 | PRKACB | 0.34203155 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Fatty acid degradation_Homo sapiens_hsa00071 | 3.32924251 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.32286559 |
| 3 | Propanoate metabolism_Homo sapiens_hsa00640 | 3.17630539 |
| 4 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.09674140 |
| 5 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 3.09368233 |
| 6 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.09315495 |
| 7 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.66698265 |
| 8 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.65326287 |
| 9 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.60433186 |
| 10 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.51065284 |
| 11 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.47176402 |
| 12 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.46546459 |
| 13 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.45400231 |
| 14 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.43880908 |
| 15 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.32399160 |
| 16 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.15265799 |
| 17 | * Peroxisome_Homo sapiens_hsa04146 | 2.04431472 |
| 18 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.99429464 |
| 19 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.89189078 |
| 20 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.77864920 |
| 21 | Asthma_Homo sapiens_hsa05310 | 1.77492258 |
| 22 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.77325620 |
| 23 | Carbon metabolism_Homo sapiens_hsa01200 | 1.73247423 |
| 24 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.67600547 |
| 25 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.64660974 |
| 26 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.63270418 |
| 27 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.57306952 |
| 28 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.48562704 |
| 29 | Other glycan degradation_Homo sapiens_hsa00511 | 1.47668256 |
| 30 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.42030754 |
| 31 | Bile secretion_Homo sapiens_hsa04976 | 1.39036151 |
| 32 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.36275331 |
| 33 | * Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.35298948 |
| 34 | Allograft rejection_Homo sapiens_hsa05330 | 1.34834104 |
| 35 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.32623401 |
| 36 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.31883698 |
| 37 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.31573336 |
| 38 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.30890538 |
| 39 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.30770817 |
| 40 | Histidine metabolism_Homo sapiens_hsa00340 | 1.28991196 |
| 41 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.19274676 |
| 42 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.17691687 |
| 43 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.17594661 |
| 44 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.17045898 |
| 45 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.16153636 |
| 46 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.14138278 |
| 47 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.10664638 |
| 48 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.10303271 |
| 49 | Retinol metabolism_Homo sapiens_hsa00830 | 1.09919859 |
| 50 | Lysosome_Homo sapiens_hsa04142 | 1.02326114 |
| 51 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.00340331 |
| 52 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.99214069 |
| 53 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.97910830 |
| 54 | Pertussis_Homo sapiens_hsa05133 | 0.97242175 |
| 55 | Leishmaniasis_Homo sapiens_hsa05140 | 0.96719556 |
| 56 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.96649989 |
| 57 | Lysine degradation_Homo sapiens_hsa00310 | 0.95005034 |
| 58 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.93503134 |
| 59 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.92843341 |
| 60 | ABC transporters_Homo sapiens_hsa02010 | 0.90819678 |
| 61 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.90438923 |
| 62 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.90002756 |
| 63 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.84627026 |
| 64 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.84418108 |
| 65 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.82886410 |
| 66 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.82191714 |
| 67 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.81010093 |
| 68 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.79462730 |
| 69 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.76938500 |
| 70 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.76184258 |
| 71 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.71390202 |
| 72 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.70379991 |
| 73 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.68059757 |
| 74 | Sulfur relay system_Homo sapiens_hsa04122 | 0.65782500 |
| 75 | Insulin resistance_Homo sapiens_hsa04931 | 0.65206564 |
| 76 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.63778830 |
| 77 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.63586391 |
| 78 | Parkinsons disease_Homo sapiens_hsa05012 | 0.61140562 |
| 79 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.60973236 |
| 80 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.60890655 |
| 81 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.58742475 |
| 82 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.58579778 |
| 83 | Tuberculosis_Homo sapiens_hsa05152 | 0.58371851 |
| 84 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.58347319 |
| 85 | Viral myocarditis_Homo sapiens_hsa05416 | 0.57057358 |
| 86 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.55972604 |
| 87 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.50042930 |
| 88 | Alzheimers disease_Homo sapiens_hsa05010 | 0.49871437 |
| 89 | Metabolic pathways_Homo sapiens_hsa01100 | 0.49601934 |
| 90 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.47303537 |
| 91 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.47011155 |
| 92 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.46052576 |
| 93 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.43093090 |
| 94 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.42749770 |
| 95 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.42693359 |
| 96 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.41962268 |
| 97 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.41062711 |
| 98 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.40111037 |
| 99 | Galactose metabolism_Homo sapiens_hsa00052 | 0.39862173 |
| 100 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.39620252 |
| 101 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.36746652 |
| 102 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.34591304 |
| 103 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.34201337 |
| 104 | Mineral absorption_Homo sapiens_hsa04978 | 0.31970762 |
| 105 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.31709903 |
| 106 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.31220937 |
| 107 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.30982241 |
| 108 | Phagosome_Homo sapiens_hsa04145 | 0.30550816 |
| 109 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.29149280 |
| 110 | Huntingtons disease_Homo sapiens_hsa05016 | 0.28982319 |
| 111 | Legionellosis_Homo sapiens_hsa05134 | 0.28477202 |
| 112 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.28150026 |
| 113 | Hepatitis C_Homo sapiens_hsa05160 | 0.27865832 |
| 114 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.27827034 |
| 115 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.27462615 |
| 116 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.24884219 |
| 117 | Circadian rhythm_Homo sapiens_hsa04710 | 0.23777609 |
| 118 | Insulin secretion_Homo sapiens_hsa04911 | 0.21429728 |
| 119 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.11853231 |
| 120 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.11699841 |
| 121 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.11393104 |
| 122 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.10553576 |
| 123 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.09538216 |
| 124 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.09455090 |
| 125 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.09051610 |
| 126 | Prion diseases_Homo sapiens_hsa05020 | 0.08062119 |
| 127 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.07324096 |
| 128 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.06367399 |
| 129 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.06055377 |
| 130 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.05435370 |
| 131 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.05129952 |
| 132 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.05010206 |

